Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.34 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 6/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.32 |
| ▸ | GSR | P00390 | 2/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.32 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.32 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azaserine SCHEMBL8862 | 1.00 | SLC1A5 (0.38) | SLC1A5NOS3NOS1NOS2IDO1 | |
| Azaserine SCHEMBL487222 | 1.00 | SLC1A5 (0.38) | SLC1A5NOS3NOS1NOS2IDO1 | |
| Azaserine SCHEMBL3312110 | 1.00 | SLC1A5 (0.38) | SLC1A5NOS3NOS1NOS2IDO1 | |
| Azaserine SCHEMBL27500218 | 0.98 | SLC1A5 (0.37) | SLC1A5NOS3NOS1NOS2IDO1 | |
| Azaserine SCHEMBL607082 | 0.98 | SLC1A5 (0.37) | SLC1A5NOS3NOS1NOS2IDO1 | |
| SCHEMBL607081 | 0.84 | — | — | |
| Azaserine SCHEMBL6824548 | 0.82 | ALOX15 (0.47) | NOS3NOS1NOS2CYP1A2GRIK1 | |
| SCHEMBL31237462 | 0.81 | IDO1 (0.40) | SLC1A5NOS3NOS1NOS2IDO1 | |
| SCHEMBL26934495 | 0.81 | IDO1 (0.40) | SLC1A5NOS3NOS1NOS2IDO1 | |
| Azaserine SCHEMBL81760 | 0.78 | ALDH1A1 (0.41) | SLC1A5IDO1SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 31931 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137794-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SYSTIMMUNE INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-0081107-B1 | PROCESS FOR PRODUCING L-TRYPTOPHAN BY FERMENTATION | AJINOMOTO CO., INC. (JP) | 1986-09-10 | — | — | EP | claimed |
| US-4601982-A | Method for producing L-tryptophan by fermentation with a brevibacterium flavum mutant | AJINOMOTO COMPANY INCORPORATED (JP) | 1986-07-22 | — | — | US | claimed |
| EP-0105360-A4 | ANTIBODIES HAVING DUAL SPECIFICITIES, THEIR PREPARATION AND USES THEREFOR. | HYBRITECH INC (US) | 1986-07-08 | — | — | EP | claimed |
| EP-0183006-A2 | A recombinant DNA-molecule, coryneform bacteria carrying recombinant DNA and process for producing an aromatic amino acid by using the same | AJINOMOTO CO., INC. (JP) | 1986-06-04 | — | — | EP | claimed |
| US-4560652-A | BACILLUS MUTANT AZASERINE, METHYL-TRYPTOPHAN AND FLUORO-TRYPTOPHAN RESISTANT; FEEDS | AJINOMOTO CO., INC. (JP) | 1985-12-24 | — | — | US | claimed |
| EP-0160550-A2 | Human lymphoblastoid cell line and hybridomas derived therefrom and antibodies produced from such hybridomas, and the production and use of the aforesaid | CETUS CORPORATION (US) | 1985-11-06 | — | — | EP | claimed |
| EP-0118917-A2 | Method for production of biologically active substances | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1984-09-19 | — | — | EP | claimed |
| EP-0105360-A1 | ANTIBODIES HAVING DUAL SPECIFICITIES, THEIR PREPARATION AND USES THEREFOR | HYBRITECH INCORPORATED (US) | 1984-04-18 | — | — | EP | claimed |
| WO-1983003679-A1 | ANTIBODIES HAVING DUAL SPECIFICITIES, THEIR PREPARATION AND USES THEREFOR | HYBRITECH INC (US) | 1983-10-27 | — | — | WO | claimed |
| EP-0081107-A2 | Process for producing L-tryptophan by fermentation | AJINOMOTO CO., INC. (JP) | 1983-06-15 | — | — | EP | claimed |